Composite Hemangioendothelioma
Authors:
- Masaharu FukunagaMFMasaharu Fukunaga
- Koyu SuzukiKSKoyu Suzuki
- Noriko SaegusaNSNoriko Saegusa
- Andrew L. FolpeAFAndrew L. Folpe
- 1 October 2007
- journal article
- case report
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 31 (10) , 1567-1572
Abstract
Composite hemangioendothelioma (HE) is a low-grade malignant vascular tumor showing varying combinations of benign, low-grade malignant, and malignant vascular components. The predominant histologic components are histologically identical to epithelioid HE and retiform HE. To our knowledge, there have been only 12 cases of composite HE reported in the English literature and its nature and biologic behavior remains unknown. In this study, the clinicopathologic and immunohistochemical features of 5 cases of composite HE including a case with associated Maffucci syndrome are described. The patients were 4 females and 1 male with a median age of 43.4 years (range, 22 to 75 y). All tumors occurred in the dermis and/or subcutis. The tumors arose in the foot or lower leg in 3 patients, in the jaw in 1 patient, and as multiple tumors in the left upper extremity in 1 patient. Two patients had congenital tumors, in the lower thigh and foot, and upper extremity, respectively. The lesions were usually of several years duration. The size of individual tumors ranged from 1.5 to 30 cm. The tumors were composed of a complex admixture of histologic components resembling various vascular lesions. The predominant components, present in all cases, resembled retiform HE and epithelioid HE. Angiosarcomalike areas were observed in 3 cases. Lymphangiomalike areas were found in 2 cases. Areas of spindle cell hemangioma, cavernous hemangioma, or arteriovenous malformation were identified in 1 case each. The 2 congenital cases, which exhibited multiple lesions, had angiosarcomalike components and an angiomatosislike growth pattern. One patient each was associated with Kasabach-Merritt or Maffucci syndrome. Immunohistochemically, all tumors showed expression of at least 2 endothelial markers (CD31, CD34, and/or factor VIII-related antigen). Of 4 cases with follow up (median duration, 8.6 y), 1 tumor recurred locally. To date, none of the patients have developed metastases. There was no difference of biologic behavior among cases with various combinations of histology in this study and previously reported cases. We conclude that composite HE should continue to be regarded as a low-grade malignant vascular tumor (HE), with significant potential for local recurrence, but little if any potential for distant metastasis.Keywords
This publication has 12 references indexed in Scilit:
- Composite cutaneous haemangioendothelioma: case report and review of the literatureClinical and Experimental Dermatology, 2005
- Congenital composite hemangioendothelioma: case report and reappraisal of the hemangioendothelioma spectrumJournal of Cutaneous Pathology, 2002
- Composite HemangioendotheliomaAmerican Journal of Surgical Pathology, 2000
- Epithelioid Hemangioendothelioma of Skin and Soft Tissues: Clinicopathologic and Immunohistochemical Study of 30 CasesAmerican Journal of Surgical Pathology, 1997
- Spindle Cell HemangioendotheliomaAmerican Journal of Surgical Pathology, 1996
- Multiple Enchondromas Associated with Spindle-Cell HemangioendotheliomasAmerican Journal of Surgical Pathology, 1995
- Spindle cell hemangioendothelioma: An immunohistochemical and flow cytometric study of six casesPathology International, 1995
- Angiomatosis of Soft Tissue An Analysis of the Histologic Features and Clinical Outcome in 51 CasesAmerican Journal of Surgical Pathology, 1992
- Spindle and Histiocytoid (Epithelioid) Hemangioendothelioma: Primary in Lymph NodeAmerican Journal of Clinical Pathology, 1986
- Maffucciʼs SyndromeJournal of Bone and Joint Surgery, 1973